Related Experiment Video
Updated: Jan 26, 2026
10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
13.2K
Mucosal vaccines and technology
A Miquel-Clopés1, E G Bentley2, J P Stewart2
1Gut Microbes and Health Research Programme, Quadram Institute Bioscience, Norwich, UK.
Clinical and Experimental Immunology
|April 10, 2019
Summary
Developing effective vaccines is crucial for global health, especially for mucosal pathogens. This review explores challenges and new technologies to improve mucosal vaccine delivery systems.
Area of Science:
- Vaccinology
- Infectious Disease Control
- Biotechnology
Background:
- A significant global burden of infectious diseases affects both humans and animals.
- Many pathogens target mucosal sites, necessitating specialized vaccine strategies.
- Current vaccine development faces challenges, particularly in delivering effective mucosal immunity.
Purpose of the Study:
- To summarize the key impediments in developing effective mucosal vaccines.
- To review emerging technologies designed to overcome current vaccine delivery limitations.
- To highlight advancements in mucosal vaccine development for infectious disease prevention.
Main Methods:
- Literature review of existing research on vaccine development.
- Analysis of challenges associated with mucosal vaccine delivery systems.
- Survey of novel and emerging technologies for enhancing mucosal immunity.
Main Results:
- Identified significant obstacles in creating vaccines that induce mucosal immunity.
- Highlighted the critical role of delivery systems in vaccine efficacy.
- Cataloged innovative technologies addressing these delivery challenges.
Conclusions:
- Overcoming delivery system limitations is paramount for advancing mucosal vaccines.
- Emerging technologies offer promising solutions for infectious disease prevention.
- Effective mucosal vaccines are essential for reducing the global burden of disease.
Related Concept Videos
01:51Vaccinations
51.3K
Overview
51.3K
01:25Mucosal Barrier of the Stomach
2.1K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.1K
01:30Cancer Vaccines
990
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
990
01:31Hybridoma Technology
17.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.4K
01:30Health Information Technology and Healthcare Information System
3.3K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.3K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.2K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.2K